Global health authorities such as the World Health Organization (WHO) as well as the National Cholesterol Education Program (NCEP) have outlined diagnostic criteria for MetS, including additional indicators like microalbuminuria and elevated plasma glucose or insulin levels to assess cardiovascular risk [7,9]. Here, INS is linked to metabolic syndrome.